A detailed history of Chase Investment Counsel Corp transactions in Incyte Corp stock. As of the latest transaction made, Chase Investment Counsel Corp holds 38,630 shares of INCY stock, worth $2.61 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
38,630
Previous 39,910 3.21%
Holding current value
$2.61 Million
Previous $2.42 Million 3.22%
% of portfolio
0.83%
Previous 0.71%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

SELL
$51.18 - $63.75 $65,510 - $81,600
-1,280 Reduced 3.21%
38,630 $2.34 Million
Q2 2024

Aug 02, 2024

BUY
$51.18 - $63.75 $2.04 Million - $2.54 Million
39,910 New
39,910 $2.42 Million
Q4 2023

Feb 05, 2024

BUY
$52.16 - $64.19 $551,696 - $678,937
10,577 New
10,577 $664,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.